Treatment for Age-Related Dysphonia

Melatonin treatment for age-related insomnia.

Older people typically exhibit poor sleep efficiency and reduced nocturnal plasma melatonin levels. The daytime administration of oral melatonin to younger people, in doses that raise their plasma melatonin levels to the nocturnal range, can accelerate sleep onset. We examined the ability of similar, physiological doses to restore nighttime melatonin levels and sleep efficiency in insomniac sub...

Current Endoscopic Treatment of Dysphonia

Benign laryngeal disorders result in dysphonia because of effects on glottic closure and the vibratory characteristics of the true vocal fold. Treatment is initially directed at reversing medical conditions and patterns of abuse with surgery reserved for unresolving lesions resulting in troublesome dysphonia. Benign lesions that require surgery are excised as precisely as possible sparing overl...

Is laryngopharyngeal reflux related to functional dysphonia?

OBJECTIVES Laryngopharyngeal reflux (LPR) may be a contributing factor in chronic hoarseness. The association of LPR with functional dysphonia (FD), the most common voice clinic diagnosis, is unknown. We attempted to determine whether patients with FD have a higher rate of laryngeal exposure to acidic stomach contents than do healthy volunteers. METHODS We recruited through the voice clinic 2...

AN AMALGAMATED METHOD FOR ESTIMATING AGE-RELATED CENTILES

Age-related Macular Deg neration Ranibizumab in Treatment for Age-related Macular Degeneration

Ranibizumab is an antibody fragment (Fab) that binds and inhibits all isoforms of vascular endothelial growth factor (VEGF), which is considered the main target in neovascular age-related macular degeneration (naMd). Based on scientific evidence of the anti-VEGF antibody for the Treatment of Predominantly classic choroidal Neovascularization in aMd (aNchoR)/Minimally classic/occult Trial of the...